Skip to main content

Cibus Global (NASDAQ: CBUS) — Company Overview, News & Financial Data

Cibus Global  logo
CBUS Cibus Global
Cibus Global  primary media
Company profile

Cibus Global

Cibus Global (NASDAQ:CBUS), known for its pioneering work in agriculture technology, focuses on developing plant traits for the agricultural community through gene editing. As a forward-thinking entity, Cibus leverages advanced technologies to address the growing concerns around food security, sustainability, and crop efficiency. Their projects span across a range of staple crops, aiming to improve yield, resistance to pests and diseases, and adaptability to changing climates. The ultimate objective of Cibus is to revolutionize agriculture with non-transgenic gene editing, contributing to safer, more sustainable food production without compromising on the planet's health. Their innovative approach positions them as a key player in the global effort to meet the increasing food demands of a rapidly expanding population.

Snapshot

Public USOwnership
2010Year founded
236Employees
California, United StatesHead office
Loading Map...
Global footprint

Operations

All Locations
United States

Products and/or services of Cibus Global

  • Development of non-transgenic trait products for key crops, enhancing yield, drought tolerance and disease resistance.
  • RTDS technology platform, a faster, precise method of editing plant genomes without introducing foreign DNA.
  • Nutritionally enhanced oilseed crops, offering healthier fatty acid profiles for consumer health.
  • Agronomic trait development in staple crops like rice and wheat to improve nitrogen use efficiency.
  • Advanced breeding technologies for reducing chemical inputs in farming, promoting sustainable agriculture.
  • Custom trait development service for agriculture sector, addressing specific challenges of farmers and industries.

Cibus Global executive team

  • Craig WichnerChief Executive Officer
  • Peter R. BeethamCo-Founder, President & COO
  • Gregory F. GocalCo-Founder, Chief Scientific Officer & Executive VP
  • Rory Balfour RiggsCo-Founder & Director
  • Jason StokesChief Administrative Officer, General Counsel & Corporate Secretary
  • Cornelis BroosChief Financial Officer
  • Rosa Cheuk KimSenior Vice President of Legal
  • Noel SauerSenior Vice President of Research

Recent announcements

What Cibus Global (CBUS) has told the market, newest first.

  1. 4 | Cibus, Inc.
  2. 4 | Cibus, Inc.
  3. 4 | Cibus, Inc.
  4. 10-Q | Cibus, Inc.
  5. 8-K | Cibus, Inc.

Key financials

Reported results for Cibus Global , in USD.

Market cap
94.3M
Revenue (TTM)
4.5M
P/E ratio
—
EPS (diluted, TTM)
-1.5
Dividend yield
—
Profit margin
0.0%
Cibus Global annual revenue and income
Fiscal year endRevenueOperating incomeNet income
3.6M-67.5M-127.1M
4.3M-77M-251.4M
1.8M-318.9M-267.6M
157K-22.4M-16.9M